NCT05042739

Brief Summary

An accurate identification of individuals at ultra-high risk (UHR) based on psychometric tools to prospectively identify psychosis as early as possible is required for indicated preventive intervention. The diagnostic comparability of several psychometric tools is unknown. To address the psychometric comparability of the CAARMS, SIPS and BSABS for subjects who are the immediate family and three-generation blood kinship of patients with schizophrenia. To verify the viability and reliability of the three instruments for these subjects. subjects who all are immediate family and three-generation blood kinship of patients with schizophreniawere interviewed. All the subjects were assessed for a UHR state by three psychometric tools including CAARMS, SIPS and BSABS. The psychometric diagnosis results including at risk of psychosis (UHR+), not at risk of psychosis (UHR-), and Psychosis. Demographic and clinical characteristics interviewed by these three instruments were also measured. The inter-rater agreement was assessed for evaluation of the coherence of the three scales. Transition rates of CAARMS, SIPS and BSABS for UCH+ subjects within 2 years were also recorded.There is good diagnostic agreement between the CAARMS, SIPS and BSABS towards identification of UHR subjects who are immediate family and three-generation blood kinship of patients with schizophrenia. Also, these three instruments are reliable and valid for assessing and detecting at risk mental states in these subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
189

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 13, 2021

Completed
Last Updated

September 13, 2021

Status Verified

August 1, 2021

Enrollment Period

1.7 years

First QC Date

August 31, 2021

Last Update Submit

September 6, 2021

Conditions

Keywords

Psychosis; UHR; CAARMS;SIPS; BSABS

Outcome Measures

Primary Outcomes (3)

  • The overall agreement percent

    diagnostic comparison of CAARMS and SIPS, SIPS and BSABS, CAARMS and BSABS.

    2 years

  • the inter-rater reliability

    Inter-rater correlation (ICC) coefficients of CAARMS, SIPS and BSABS subscales.

    2 years

  • the transition rates of UHR+ to psychosis within 2 years

    Transition rates of CAARMS, SIPS and BSABS for UCH+ subjects within 2 years follow-up.

    2 years

Interventions

CAARMS;SIPS; BSABS;DIAGNOSTIC_TEST

Comprehensive Assessment of At Risk Mental State (CAARMS); Structured Interview for Psychosis-Risk Syndrome (SIPS); Bonn Scale for the Assessment of Basic Symptoms (BSABS);

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All are immediate family and three-generation blood kinship of patients with schizophrenia diagnosed in Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science \& Technology. Subjects are recruited from Wuhan Mental Health Center who can be contacted by telephone or an internet homepage.

You may qualify if:

  • all are immediate family and three-generation blood kinship of patients with schizophrenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Psychological Rehabilitation, Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science & Technology

Wuhan, Hubei, 430022, China

Location

MeSH Terms

Conditions

Psychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Peng Wang, Master

    Dept. of Psychological Rehabilitation, Affiliated Wuhan Mental Health Center, Tongji Medical College of Huazhong University of Science & Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2021

First Posted

September 13, 2021

Study Start

May 1, 2017

Primary Completion

January 1, 2019

Study Completion

April 1, 2021

Last Updated

September 13, 2021

Record last verified: 2021-08

Locations